Virulent and avirulent strains of Toxoplasma gondii which differ in their glycosylphosphatidylinositol content induce similar biological functions in macrophages

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Niehus, Sebastian ^a,b   Smith, Terry K ^c   Azzouz, Nahid ^a,k   Campos, Marco A ^d   Dubremetz, Jean François ^e   Gazzinelli, Ricardo T ^d,f,g   Schwarz, Ralph T ^a,h   Debierre Grockiego, Françoise ^a,i,j  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITÉ DE MONTPELLIER   (France)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h UNIV LILLE   (France)

ⁱ UNIVERSITÉ DE TOURS   (France)

^j CEMAGREF   (France)

^k MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 12P40; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST PARASITE INTERACTION; ISOTOPE LABELING; MACROPHAGE FUNCTION; NONHUMAN; PARASITE CULTIVATION; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITE VIRULENCE; POPULATION ABUNDANCE; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; TOXOPLASMA GONDII; TRANSCRIPTION INITIATION; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; MACROPHAGE; METABOLISM; MOUSE; PARASITOLOGY; PATHOGENICITY; TOXOPLASMA; VERO CELL LINE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; GLYCOSYLPHOSPHATIDYLINOSITOLS; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGES; MICE; TOXOPLASMA; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS;

EID: 84900314374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085386     Document Type: Article

References (60)

1. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976. (Pubitemid 38759657)
2. Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, et al. (2011) Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 41: 645-655.
3. Khan A, Miller N, Roos DS, Dubey JP, Ajzenberg D, et al. (2011) A monomorphic haplotype of chromosome Ia is associated with widespread success in clonal and nonclonal populations of Toxoplasma gondii. MBio 2: e00228-00211.
4. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, et al. (2012) Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A 109: 5844-5849.
5. Saeij JP, Boyle JP, Boothroyd JC (2005) Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 21: 476-481. (Pubitemid 41297751)
6. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, et al. (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776-1780. (Pubitemid 44969089)
7. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
8. Liesenfeld O, Kosek J, Remington JS, Suzuki Y (1996) Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184: 597-607. (Pubitemid 26324113)
9. Melo MB, Jensen KD, Saeij JP (2011) Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol 27: 487-495.
10. Boothroyd JC (2013) Have it your way: how polymorphic, injected kinases and pseudokinases enable toxoplasma to subvert host defenses. PLoS Pathog 9: e1003296.
11. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780-1783. (Pubitemid 44969090)
12. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, et al. (2011) Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci U S A 108: 9631-9636.
13. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP (2011) Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci U S A 108: 9625-9630.
14. Fleckenstein MC, Reese ML, Konen-Waisman S, Boothroyd JC, Howard JC, et al. (2012) A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol 10: e1001358.
15. Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, et al. (2010) Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8: 484-495.
16. Howard JC, Hunn JP, Steinfeldt T (2011) The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii. Curr Opin Microbiol 14: 414-421.
17. Behnke MS, Fentress SJ, Mashayekhi M, Li LX, Taylor GA, et al. (2012) The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog 8: e1002992.
18. Gavrilescu LC, Denkers EY (2001) IFN-gamma overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J Immunol 167: 902-909. (Pubitemid 32660846)
19. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167: 4574-4584. (Pubitemid 32954337)
20. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327. (Pubitemid 46122820)
21. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, et al. (2011) Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9: 472-483.
22. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, et al. (2003) Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 4: 485-490. (Pubitemid 36592442)
23. Debierre-Grockiego F, Azzouz N, Schmidt J, Dubremetz JF, Geyer H, et al. (2003) Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-alpha production in macrophages. J Biol Chem 278: 32987-32993. (Pubitemid 37055743)
24. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629. (Pubitemid 40807512)
25. McConville MJ, Ferguson MA (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem J 294 (Pt 2): 305-324. (Pubitemid 23268825)
26. Schofield L, Hackett F (1993) Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 177: 145-153. (Pubitemid 23008094)
27. Tachado SD, Schofield L (1994) Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem Biophys Res Commun 205: 984-991.
28. Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, et al. (1997) Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci U S A 94: 4022-4027.
29. Boothroyd JC, Hehl A, Knoll LJ, Manger ID (1998) The surface of Toxoplasma: more and less. Int J Parasitol 28: 3-9. (Pubitemid 28082055)
30. Lekutis C, Ferguson DJ, Grigg ME, Camps M, Boothroyd JC (2001) Surface antigens of Toxoplasma gondii: variations on a theme. Int J Parasitol 31: 1285-1292. (Pubitemid 32868708)
31. Jung C, Lee CY, Grigg ME (2004) The SRS superfamily of Toxoplasma surface proteins. Int J Parasitol 34: 285-296. (Pubitemid 38299179)
32. Azzouz N, Shams-Eldin H, Niehus S, Debierre-Grockiego F, Bieker U, et al. (2006) Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surface. Int J Biochem Cell Biol 38: 1914-1925. (Pubitemid 44425249)
33. Wasmuth JD, Pszenny V, Haile S, Jansen EM, Gast AT, et al. (2012) Integrated bioinformatic and targeted deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator of Toxoplasma virulence. MBio 3.
34. Wichroski MJ, Ward GE (2003) Biosynthesis of glycosylphosphatidylinositol is essential to the survival of the protozoan parasite Toxoplasma gondii. Eukaryot Cell 2: 1132-1136. (Pubitemid 37298727)
35. Striepen B, Zinecker CF, Damm JB, Melgers PA, Gerwig GJ, et al. (1997) Molecular structure of the "low molecular weight antigen" of Toxoplasma gondii: a glucose alpha 1-4 N-acetylgalactosamine makes free glycosylphosphatidylinositols highly immunogenic. J Mol Biol 266: 797-813. (Pubitemid 27113217)
36. Debierre-Grockiego F, Campos MA, Azzouz N, Schmidt J, Bieker U, et al. (2007) Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol 179: 1129-1137.
37. Debierre-Grockiego F, Niehus S, Coddeville B, Elass E, Poirier F, et al. (2010) Binding of Toxoplasma gondii glycosylphosphatidylinositols to galectin-3 is required for their recognition by macrophages. J Biol Chem 285: 32744-32750.
38. Grimwood BG, Hechemy K, Stevens RW (1979) Toxoplasma gondii: purification of trophozoites propagated in cell culture. Exp Parasitol 48: 282-286. (Pubitemid 10247760)
39. Azzouz N, Shams-Eldin H, Schwarz RT (2005) Removal of phospholipid contaminants through precipitation of glycosylphosphatidylinositols. Anal Biochem 343: 152-158. (Pubitemid 40978620)
40. Menon AK, Schwarz RT, Mayor S, Cross GA (1990) Cell-free synthesis of glycosyl-phosphatidylinositol precursors for the glycolipid membrane anchor of Trypanosoma brucei variant surface glycoproteins. Structural characterization of putative biosynthetic intermediates. J Biol Chem 265: 9033-9042.
41. Tomavo S, Dubremetz JF, Schwarz RT (1992) A family of glycolipids from Toxoplasma gondii. Identification of candidate glycolipid precursor(s) for Toxoplasma gondii glycosylphosphatidylinositol membrane anchors. J Biol Chem 267: 11721-11728.
42. Yamashita K, Mizuochi T, Kobata A (1982) Analysis of oligosaccharides by gel filtration. Methods Enzymol 83: 105-126.
43. Macrae JI, Ferguson MA (2005) A robust and selective method for the quantification of glycosylphosphatidylinositols in biological samples. Glycobiology 15: 131-138. (Pubitemid 40227918)
44. Smith TK, Kimmel J, Azzouz N, Shams-Eldin H, Schwarz RT (2007) The role of inositol acylation and inositol deacylation in the Toxoplasma gondii glycosylphosphatidylinositol biosynthetic pathway. J Biol Chem 282: 32032-32042. (Pubitemid 350106437)
45. Tomavo S, Couvreur G, Leriche MA, Sadak A, Achbarou A, et al. (1994) Immunolocalization and characterization of the low molecular weight antigen (4-5 kDa) of Toxoplasma gondii that elicits an early IgM response upon primary infection. Parasitology 108 (Pt 2): 139-145. (Pubitemid 24056821)
46. Pekari K, Tailler D, Weingart R, Schmidt RR (2001) Synthesis of the fully phosphorylated GPI anchor pseudohexasaccharide of Toxoplasma gondii. J Org Chem 66: 7432-7442. (Pubitemid 33029846)
47. Delude RL, Yoshimura A, Ingalls RR, Golenbock DT (1998) Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. J Immunol 161: 3001-3009. (Pubitemid 28425725)
48. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, et al. (1999) Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274: 33419-33425. (Pubitemid 129511647)
49. Pollard AM, Knoll LJ, Mordue DG (2009) The role of specific Toxoplasma gondii molecules in manipulation of innate immunity. Trends Parasitol 25: 491-494.
50. Hunter CA, Sibley LD (2012) Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 10: 766-778.
51. Gazzinelli RT, Denkers EY (2006) Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 6: 895-906. (Pubitemid 44851732)
52. Niehus S, Elass E, Coddeville B, Guerardel Y, Schwarz RT, et al. (2012) Glycosylphosphatidylinositols of Toxoplasma gondii induce matrix metalloproteinase-9 production and degradation of galectin-3. Immunobiology 217: 61-64.
53. Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, et al. (2000) Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med 192: 1563-1576.
54. Almeida IC, Camargo MM, Procopio DO, Silva LS, Mehlert A, et al. (2000) Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. Embo J 19: 1476-1485. (Pubitemid 30182155)
55. Dubey JP, Lindsay DS, Speer CA (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 11: 267-299. (Pubitemid 28197354)
56. Dzierszinski F, Mortuaire M, Cesbron-Delauw MF, Tomavo S (2000) Targeted disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3 gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces virulence in mice. Mol Microbiol 37: 574-582. (Pubitemid 30611838)
57. Khan IA, Eckel ME, Pfefferkorn ER, Kasper LH (1988) Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J Infect Dis 157: 979-984.
58. Rachinel N, Buzoni-Gatel D, Dutta C, Mennechet FJ, Luangsay S, et al. (2004) The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J Immunol 173: 2725-2735. (Pubitemid 39063134)
59. Striepen B, Tomavo S, Dubremetz JF, Schwarz RT (1992) Identification and characterisation of glycosyl-inositolphospholipids in Toxoplasma gondii. Biochem Soc Trans 20: 296S.
60. Plattner F, Yarovinsky F, Romero S, Didry D, Carlier MF, et al. (2008) Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3: 77-87. (Pubitemid 351201784)